Stockreport

U.S. FDA Approves Cost Recovery for PLX-PAD under Expanded Access Program in the Treatment of Critical Limb Ischemia

Pluristem Therapeutics, Inc.  (PSTI) 
Last pluristem therapeutics, inc. earnings: 2/6 04:10 pm Check Earnings Report
US:NASDAQ Investor Relations: pluristem.com
PDF Pluristem enters into agreement with WideTrial Inc. to conduct the programWideTrial will purchase PLX-PAD cell products from PluristemProgram makes investigational treat [Read more]